<DOC>
	<DOCNO>NCT00075959</DOCNO>
	<brief_summary>This study determine NXY-059 safe patient acute stroke cause bleeding central nervous system . The primary objective ass safety tolerability NXY-059 compare placebo .</brief_summary>
	<brief_title>Safety NXY-059 Treatment Patients Who Have Suffered From Stroke</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Disufenton sodium</mesh_term>
	<criteria>Males females Intracerebral Hemorrhage cause stroke symptom Onset symptom within 6 hour Full functional independence prior present stroke Unconsciousness Subjects unlikely complete infusion investigational product and/or unlikely undergo active medical management period due severe clinical condition . Severe illness life expectancy le 6 month . Known severe kidney disorder . Current known alcohol illicit drug abuse dependence . Pregnant breastfeeding . Treatment acetazolamide methotrexate permit infusion Participation previous clinical study within 7 day . Meets exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Stroke</keyword>
	<keyword>cerebral vascular accident</keyword>
	<keyword>CVA</keyword>
	<keyword>Hemorrhage</keyword>
	<keyword>Intracerebral Hemorrhage ( ICH )</keyword>
	<keyword>Brain Attack</keyword>
	<keyword>Cataplexy</keyword>
</DOC>